WILMINGTON, N.C.--(BUSINESS WIRE)--PPD, Inc. (Nasdaq: PPDI) today announced its global central lab operations in Beijing has earned accreditation by the College of American Pathologists (CAP), making it the company’s third central lab to meet the highest standard of excellence in enhancing patient safety and speeding drug development.
